PRFX 0.98 (-10.91%)
IL0011651580Drug ManufacturersDrug Manufacturers - Specialty & Generic

PainReform (PRFX) Competitor Comparison

We are evaluating the key criteria listed to compare PainReform (PRFX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Valuation Rank - PRFX ranking 0 / 55

These are the competitors of PainReform in the industry Drug Manufacturers - Specialty & Generic ranked by valuation rank
1. Eagle Pharmaceuticals EGRX
0.86
2. Clever Leaves Holdings CLVR
0.79
3. Vifor Pharma G2AB.F
0.79
4. Catalent CTLT
0.79
5. Teva Pharmaceutical Industries TEVA
0.79
6. Linc LNC
0.71
7. PetIQ PETQ
0.71
8. Ayr Wellness 3KJB.F
0.71
9. Phibro Animal Health PAHC
0.71
10. ProPhase Labs PRPH
0.71
11. Amneal Pharmaceuticals AMRX
0.71
12. Procaps Group PROC
0.64
13. Perrigo PRGO
0.64
14. Taro Pharmaceutical Industries TARO
0.64
15. Embecta EMBC
0.64
16. Amphastar Pharmaceuticals AMPH
0.64
17. Universe Pharmaceuticals UPC
0.64
18. Jupiter Wellness JUPW
0.57
19. Elanco Animal Health ELAN
0.57
20. Tilray Brands TLRY
0.57
21. Alpha Teknova TKNO
0.57
22. Alimera Sciences ALIM
0.57
23. Collegium Pharmaceutical COLL
0.57
24. Organogenesis Holdings ORGO
0.57
25. Kolinpharma KIP.MI
0.57
26. Evolus EOLS
0.5
27. Ascend Wellness Holdings AAWH
0.5
28. Cronos Group CRON
0.5
29. Curaleaf Holdings CURLF
0.5
30. Emergent BioSolutions EBS
0.5
31. Flora Growth FLGC
0.5
32. Green Thumb Industries R9U2.F
0.5
33. Ironwood Pharmaceuticals IRWD
0.5
34. Kamada KMDA
0.5
35. Neoleukin Therapeutics NLTX
0.5
36. Regencell Bioscience Holdings RGC
0.5
37. Solid Biosciences SLDB
0.5
38. Societal CDMO SCTL
0.43
39. Bausch Health Companies BHC
0.43
40. Pacira BioSciences PCRX
0.43
41. Cumberland Pharmaceuticals CPIX
0.43
42. Zoetis ZTS
0.43
43. Journey Medical DERM
0.43
44. Theratechnologies THTX
0.43
45. MedAvail Holdings MDVL
0.36
46. Relmada Therapeutics RLMD
0.36
47. ANI Pharmaceuticals ANIP
0.36
48. OptiNose OPTN
0.36
49. Harrow Health HROW
0.29
50. Alvotech ALVO
0.29
51. Supernus Pharmaceuticals SUPN
0.29
52. Biofrontera BFRI
0.21
53. Zynerba Pharmaceuticals ZYNE
0.07
54. SCYNEXIS SCYX
0.07
55. Avadel Pharmaceuticals AVDL
0.07

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.